Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy - PubMed (original) (raw)
. 1988 Sep 1;48(17):4749-55.
Affiliations
- PMID: 3409216
Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy
J L Evelhoch et al. Cancer Res. 1988.
Abstract
Flavone acetic acid (FAA), a new drug with broad activity against transplanted solid tumors of mice, induces nonrepairable DNA single strand breaks that correlate with therapeutic efficacy. To test the hypothesis that the inability of the cells to repair single strand breaks is associated with a disruption of tumor energy metabolism, in vivo 31P nuclear magnetic resonance (NMR) spectra were acquired from s.c. implanted Glasgow osteogenic sarcomas in C57BL/6 x DBA/2 F1 mice both before and after treatment with FAA i.v. at 100, 150, or 200 mg/kg and from a control (no treatment) group (n = 4 in each group). While FAA produced a dose-dependent decrease in both the nucleoside triphosphates level and pH, only treatment with an efficacious dose of 200 mg/kg resulted in both a reduction in pH and a complete loss of nucleoside triphosphates from the NMR spectrum at 4 h with no recovery until 48 h and little recovery out to 72 h. The ATP concentration determined by high pressure liquid chromatography in a parallel set of experiments was 5.59 +/- 1.16 (SE) mumol/g (wet weight) in control tumors (n = 9) and 0.24 +/- 0.12 mumol/g (wet weight) at 4 h after 200 mg/kg FAA (n = 7). To examine the possibility that the loss of ATP and decreased pH are associated with a reduction in tumor blood flow, we used 2H NMR to monitor the washout of D2O injected directly into the tumor both before and 4 h after treatment with 200 mg/kg FAA. The pretreatment tumor blood flow of 12.4 +/- 1.7 ml/min/100 g was reduced to 1.9 +/- 0.5 ml/min/100 g at 4 h after treatment (n = 3). The FAA-induced reduction of both tumor blood flow and ATP may play an important role in its mechanism of action and should be considered in the combination of FAA with other drugs or therapeutic modalities. In addition, because 31P NMR can be used clinically, it should provide a nonambiguous early indicator of activity for clinical trials of FAA.
Similar articles
- Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo.
Bissery MC, Valeriote FA, Chabot GG, Crissman JD, Yost C, Corbett TH. Bissery MC, et al. Cancer Res. 1988 Mar 1;48(5):1279-85. Cancer Res. 1988. PMID: 3422592 - [A novel in vivo 31P-nuclear magnetic resonance technique for assessment of teratogenicity induced by environmental endocrine disrupters in mice].
Manabe N, Sugimoto M, Morita M, Tanaka T, Yamaguchi M, Miyamoto H. Manabe N, et al. Nihon Rinsho. 2000 Dec;58(12):2482-5. Nihon Rinsho. 2000. PMID: 11187741 Review. Japanese.
Cited by
- Identification and induction of cytochrome P450s involved in the metabolism of flavone-8-acetic acid in mice.
Pham MH, Rhinn H, Auzeil N, Regazzetti A, Harami DE, Scherman D, Chabot GG. Pham MH, et al. Drug Metab Lett. 2011 Apr;5(2):73-84. doi: 10.2174/187231211795305221. Drug Metab Lett. 2011. PMID: 21457135 Free PMC article. - Applications of magnetic resonance in model systems: cancer therapeutics.
Evelhoch JL, Gillies RJ, Karczmar GS, Koutcher JA, Maxwell RJ, Nalcioglu O, Raghunand N, Ronen SM, Ross BD, Swartz HM. Evelhoch JL, et al. Neoplasia. 2000 Jan-Apr;2(1-2):152-65. doi: 10.1038/sj.neo.7900078. Neoplasia. 2000. PMID: 10933074 Free PMC article. Review. - Energetics of nutrition and polyamine-related tumor growth alterations in experimental cancer.
Westin T, Soussi B, Idström JP, Lindnér P, Edström S, Lydén E, Gustavsson B, Hafström L, Lundholm K. Westin T, et al. Br J Cancer. 1993 Oct;68(4):662-7. doi: 10.1038/bjc.1993.405. Br J Cancer. 1993. PMID: 8398689 Free PMC article. - Preclinical in vitro and in vivo activity of 5,6-dimethylxanthenone-4-acetic acid.
Laws AL, Matthew AM, Double JA, Bibby MC. Laws AL, et al. Br J Cancer. 1995 Jun;71(6):1204-9. doi: 10.1038/bjc.1995.234. Br J Cancer. 1995. PMID: 7779712 Free PMC article. - Induction of tumour necrosis factor-alpha by single and repeated doses of the antitumour agent 5,6-dimethylxanthenone-4-acetic acid.
Philpott M, Baguley BC, Ching LM. Philpott M, et al. Cancer Chemother Pharmacol. 1995;36(2):143-8. doi: 10.1007/BF00689199. Cancer Chemother Pharmacol. 1995. PMID: 7767951
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous